First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
20.05
+1.95 (10.77%)
At close: Apr 28, 2026, 4:00 PM EDT
19.56
-0.49 (-2.44%)
After-hours: Apr 28, 2026, 7:58 PM EDT
TRAX Market Cap
TRAX has a market cap or net worth of $696.71 million as of April 28, 2026.
Market Cap
696.71M
Enterprise Value
399.19M
1-Year Change
n/a
Ranking
Category
Stock Price
$20.05
Market Cap Chart
Since April 6, 2026, TRAX's market cap has increased from $660.23M to $696.71M, an increase of 5.53%. That is a compound annual growth rate of 154.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 628.95M | -4.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 696.73M |
| Alpha Tau Medical | 696.16M |
| Arvinas | 658.16M |
| Forte Biosciences | 656.02M |
| Prime Medicine | 649.88M |
| CorMedix | 613.31M |
| Aclaris Therapeutics | 612.97M |
| Shattuck Labs | 583.49M |